Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cell biology"
DOI: 10.1016/j.ejcb.2020.151097
Abstract: Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD), Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) along with some other less common diseases generally described by the… read more here.
Keywords: neurodegenerative disease; mesenchymal stromal; mscs neurodegenerative; stromal cells ... See more keywords
Therapeutic strategies for Parkinson’s disease: promising agents in early clinical development
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2020.1814252
Abstract: ABSTRACT Introduction To date, no drug has demonstrated clinically indisputable neuroprotective efficacy in Parkinson’s disease (PD). We also have no effective symptomatic treatment for disabling symptoms such as balance problems, and dementia, and we need… read more here.
Keywords: therapeutic strategies; strategies parkinson; parkinson disease; promising agents ... See more keywords